Basics Immunocore Holdings IPO Date: February 5, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.87B Activated in VL: True Average Daily Range Avg Daily Range: $1.04 | 2.50% Avg Daily Range (30 D): $0.48 | 1.44% Avg Daily Range (90 D): $0.64 | 1.95% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .28M Avg Daily Volume (90 D): .32M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 1,681 Avg Inst. Trade: $1.78M Avg Inst. Trade (30 D): $.91M Avg Inst. Trade (90 D): $1.19M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.52M Avg Closing Trade (30 D): $.73M Avg Closing Trade (90 D): $.95M Avg Closing Volume: 32.88K     News Aug 7, 2025 @ 3:54 PM Immunocore (IMCR) Q2 Revenue Jumps 30% Source: Jesterai Mar 10, 2025 @ 7:00 PM Immunocore presents initial multiple ascending dos... Source: N/A Mar 6, 2025 @ 6:00 PM TCR Therapy Clinical Trial Pipeline Accelerates as... Source: Delveinsight Jan 6, 2025 @ 12:00 PM Immunocore to present at the 43rd Annual J.P. Morg... Source: N/A Jan 2, 2025 @ 12:00 PM Immunocore appoints Travis Coy, previously a Non-E... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.41 $-.2 $.1 Diluted EPS $-.41 $-.2 $.1 Revenue $ 356.15M $ 97.96M $ 93.88M Gross Profit $ 353.5M $ 96.92M $ 93.05M Net Income / Loss $ -20.31M $ -10.3M $ 5.02M Operating Income / Loss $ -46.45M $ -14.88M $ -3.62M Cost of Revenue $ 2.65M $ 1.04M $ .83M Net Cash Flow $ -17.05M $ 11.09M $ 21.11M PE Ratio